Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 5
1990 5
1991 7
1992 7
1993 1
1994 5
1995 4
1996 11
1997 5
1998 6
1999 5
2000 5
2001 9
2002 10
2003 4
2004 5
2005 5
2006 7
2007 10
2008 9
2009 8
2010 5
2011 3
2012 2
2013 8
2014 8
2015 13
2016 8
2017 9
2018 11
2019 9
2020 21
2021 19
2022 14
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic strategies to overcome taxane resistance in cancer.
Das T, Anand U, Pandey SK, Ashby CR Jr, Assaraf YG, Chen ZS, Dey A. Das T, et al. Among authors: ashby cr jr. Drug Resist Updat. 2021 Mar;55:100754. doi: 10.1016/j.drup.2021.100754. Epub 2021 Feb 27. Drug Resist Updat. 2021. PMID: 33691261 Review.
Modulating ROS to overcome multidrug resistance in cancer.
Cui Q, Wang JQ, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR Jr, Yang DH, Chen ZS. Cui Q, et al. Among authors: ashby cr jr. Drug Resist Updat. 2018 Nov;41:1-25. doi: 10.1016/j.drup.2018.11.001. Epub 2018 Nov 14. Drug Resist Updat. 2018. PMID: 30471641 Review.
Doxycycline for ESBL-E Cystitis.
Jodlowski T, Ashby CR, Nath SG. Jodlowski T, et al. Among authors: ashby cr. Clin Infect Dis. 2021 Jul 1;73(1):e274-e275. doi: 10.1093/cid/ciaa1898. Clin Infect Dis. 2021. PMID: 33372961 No abstract available.
Darovasertib, a novel treatment for metastatic uveal melanoma.
Cao L, Chen S, Sun R, Ashby CR Jr, Wei L, Huang Z, Chen ZS. Cao L, et al. Among authors: ashby cr jr. Front Pharmacol. 2023 Jul 28;14:1232787. doi: 10.3389/fphar.2023.1232787. eCollection 2023. Front Pharmacol. 2023. PMID: 37576814 Free PMC article. Review.
Nivolumab and relatlimab for the treatment of melanoma.
Chen XY, Li YD, Xie Y, Cao LQ, Ashby CR Jr, Zhao H, Chen ZS. Chen XY, et al. Among authors: ashby cr jr. Drugs Today (Barc). 2023 Feb;59(2):91-104. doi: 10.1358/dot.2023.59.2.3509756. Drugs Today (Barc). 2023. PMID: 36811409 Review.
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.
Chavda V, Zajac KK, Gunn JL, Balar P, Khadela A, Vaghela D, Soni S, Ashby CR Jr, Tiwari AK. Chavda V, et al. Among authors: ashby cr jr. Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1821. doi: 10.1002/cnr2.1821. Epub 2023 Jun 21. Cancer Rep (Hoboken). 2023. PMID: 37344125 Free PMC article. Review.
256 results